The median of MCP-1 plasma levels in the high CK-18 group (351.5 pg/mL) in our study were significantly higher than those in the low CK-18 group (330.5 pg/mL), but were comparable to those in NASH patients (350 pg/mL). The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.